Not applicableEnded earlyNCT01357408What this trial is testingHeart Failure and Risk of Re-Admissions Determined by Abnormal REVEAL ParametersWho this might be right forHeart Failure Thomas Jefferson University 40
Large-scale testing (Phase 3)Study completedNCT00551447What this trial is testingA Study Comparing Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Patients at Risk for Heart Disease (0653-023)(COMPLETED)Who this might be right forCoronary Disease Organon and Co 616
Large-scale testing (Phase 3)Study completedNCT00685776What this trial is testingStudy to Assess the Tolerability and Efficacy of Anacetrapib in Patients With Coronary Heart Disease (CHD) or CHD Risk-Equivalent Disease (MK-0859-019)Who this might be right forCoronary Heart Disease (CHD)CHD Risk-Equivalent Disease Merck Sharp & Dohme LLC 1,623
Not applicableStudy completedNCT00360217What this trial is testingThe Triglyceride Lowering Effect of an Omega-3 Fat (DHA) in Addition to Statin Therapy for Patients With CAD or DiabetesWho this might be right forHypertriglyceridemia (TG>200<500)HyperlipidemiaCoronary Artery Disease+2 more Maine Center for Lipids and Cardiovascular Health 60
Testing effectiveness (Phase 2)Study completedNCT00353522What this trial is testingRO4607381 in Patients With Coronary Heart Disease (CHD) or a CHD Risk Equivalent.Who this might be right forCoronary Heart Disease Hoffmann-La Roche 135
Not applicableLooking for participantsNCT03987633What this trial is testingEMPOWER-1: A Multi-site Clinical Cohort Research Study to Reduce Health InequalityWho this might be right forAtrial FibrillationCoronary Heart DiseaseCardiovascular Diseases+19 more Future Genetics Limited 200,000
Large-scale testing (Phase 3)Ended earlyNCT00134264What this trial is testingA Study Examining Torcetrapib/Atorvastatin And Atorvastatin Effects On Clinical CV Events In Patients With Heart DiseaseWho this might be right forCoronary DiseaseDiabetes Mellitus Pfizer 15,067
Not applicableStudy completedNCT01083914What this trial is testingComparing Blood Loss, RBC Transfusions and Inflammatory Marker Changes Among Methods of CPBWho this might be right forCoronary Artery Disease Baylor Research Institute 102
Large-scale testing (Phase 3)Study completedNCT00653588What this trial is testingPolaris - Crestor 40 mg vs Atorvastatin 80 mg for 26 WeeksWho this might be right forHypercholesterolemiaCoronary Heart Disease AstraZeneca
Testing effectiveness (Phase 2)Study completedNCT00655538What this trial is testingA Study Assessing the Effect of RO4607381 on Vascular Function in Patients With Coronary Heart Disease (CHD) or CHD-Risk Equivalent PatientsWho this might be right forCoronary Heart Disease Hoffmann-La Roche 476
Large-scale testing (Phase 3)Study completedNCT01516541What this trial is testingDalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular DiseaseWho this might be right forCardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Hoffmann-La Roche 2,220
Not applicableStudy completedNCT03016936What this trial is testingMET: REevaluation for Perioperative cArdIac Risk (MET-REPAIR)Who this might be right forNon Cardiac Surgery European Society of Anaesthesiology 15,000
Not applicableStudy completedNCT05355948What this trial is testingA Clinical Trial to Evaluate the Detection of Atrial Fibrillation for an One Day Versus More Than or Equal to Eight Days Using MEMO Patch PLUS in Individuals Aged ≥ 75 Years, or Those at High Risk of StrokeWho this might be right forAtrial Fibrillation/Flutter in Patients With High Risk of Stroke Yonsei University 1,000
Testing effectiveness (Phase 2)Study completedNCT00269048What this trial is testingSB-480848 In Subjects With Coronary Heart DiseaseWho this might be right forAtherosclerosis GlaxoSmithKline 969
Post-approval studies (Phase 4)Active Not RecruitingNCT06249165What this trial is testingVictORION-INCLUSION: Evaluating Inclisiran for Cholesterol Managment in Heart DiseaseWho this might be right forAtherosclerotic Cardiovascular Disease Duke University 130
Not applicableStudy completedNCT05686330What this trial is testingDetection and Quantification of Atrial Fibrillation in High-risk Patients Using a Smartwatch Wearable (Apple Watch)Who this might be right forAtrial Fibrillation Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC) 436